U.S. Stock News

If you are wondering whether Franklin Resources stock still offers value at current levels, it helps to start with how the market has been treating it recently and what that might imply about expectations. The stock last closed at US$30.52, with returns of 1.8% over 7 days, 28.3% over 30 days, 28.2% year to date, and 54.8% over 1 year. This puts recent price action firmly on investors' radar. Recent news coverage has focused on Franklin Resources' position as a global asset manager and its...

Why Huntsman Stock Is Back In Focus After Recent Company Updates Huntsman (HUN) has drawn fresh attention after management highlighted recent price increases, efforts to offset higher costs, and comments on demand trends and margins heading into the second quarter. See our latest analysis for Huntsman. Recent company updates on pricing, demand and margins have come alongside a 44.65% year to date share price return, while the 1 year total shareholder return of 30.18% contrasts with a weaker 3...

ResMed (RMD) recently combined a CFO transition with quarterly results that showed higher sales, net income and earnings per share year over year, a mix that tends to sharpen investor focus on the stock. See our latest analysis for ResMed. Even with higher quarterly sales and earnings, ResMed’s recent share price has been under pressure, with a 30 day share price return of an 8.48% decline and a 90 day share price return of a 23.83% decline. The 1 year total shareholder return of a 14.31%...

In the past quarter, NOV Inc. repurchased 3,500,000 shares for US$67 million, completing a broader buyback of 40,475,436 shares for US$611.23 million under its April 26, 2024 authorization, while reporting first-quarter 2026 revenue of US$2,052 million and net income of US$19 million, both lower than a year earlier. The earnings release, guidance for a 4% to 6% year-over-year revenue decline in the second quarter of 2026, and Barclays’ downgrade to Underweight despite a more positive view on...

Mueller Water Products (NYSE:MWA) has flagged a higher priority on acquisitions, with management highlighting more active work on potential targets. The company is planning to use its balance sheet and increased M&A readiness to expand its portfolio and support net sales growth. This marks a shift in capital allocation focus toward deals that could reshape its market presence and operating profile. Mueller Water Products focuses on water infrastructure products and services, an area that...

Chubb (NYSE:CB) has formed an alliance with Verified Clinical Trials to support risk management and data quality in clinical research. The partnership focuses on research subject safety, data integrity, and reducing operational and regulatory risks using VCT's subject registry technology. This development extends Chubb's activity beyond traditional insurance coverage into technology driven clinical trial risk solutions. For investors tracking Chubb at a current share price of $321.28, the...

Why Biogen (BIIB) is on investors’ radar today Biogen (BIIB) has drawn fresh attention after recent share price moves, with the stock up about 9% over the past month but showing a roughly 5% decline over the past 3 months. See our latest analysis for Biogen. The recent 8.98% 1 month share price return, alongside a 7.63% year to date share price return and 61.65% 1 year total shareholder return, suggests momentum has picked up again after weaker 3 year and 5 year total shareholder returns. If...

Why Buckle Stock Is Back On Investors’ Radar Buckle (BKE) is attracting fresh attention after a period of mixed short term returns, with the stock showing a small gain over the past month and a modest rise over the past 3 months. See our latest analysis for Buckle. Short term share price momentum has cooled, with a 1 day share price return decline of 4.01% and a 7 day share price return decline of 5.84%, while the 1 year total shareholder return of 53.77% still points to a strong longer term...

If you are wondering whether Constellation Energy stock is trading at an attractive price or starting to look stretched, the key is understanding what the current valuation is really telling you. The stock last closed at US$311.28, with returns of 14.2% over the past 30 days and 15.6% over the last year, set against a 15.0% decline year to date and a very large gain over three years. Recent headlines around Constellation Energy have focused on its position within the utilities sector and...

In early May 2026, TowneBank was caught up in a broader regional bank pullback as renewed U.S.-Iran tensions drove oil prices higher and pushed Treasury yields toward nine-month highs, rekindling stagflation worries. This episode highlights how quickly the macro backdrop, especially inflation-driven moves in the yield curve, can alter perceptions of earnings resilience for regional lenders like TowneBank. We’ll now examine how this inflation-driven shift in Treasury yields may influence...

If you are wondering whether Entergy stock still offers value at recent prices, it helps to step back and look at both the recent returns and what they might be pricing in. The stock last closed at US$112.02, with a 7 day return of a 5% decline, a 30 day return of a 1.6% decline, and a gain of 19.3% year to date and 37.9% over the past year, with multi year returns that have been very large over 3 and 5 years. Recent price moves sit against a backdrop of ongoing interest in regulated...

Why Independent Bank's new buyback is drawing attention Independent Bank (INDB) has put a fresh US$200 million share repurchase program on the table, running through April 2027, which immediately puts capital returns and valuation front and center for investors. See our latest analysis for Independent Bank. Independent Bank's share price has softened recently, with a 9.05% 90 day share price return, yet the 1 year total shareholder return of 30.63% and 3 year total shareholder return of...

In the first quarter of 2026, Zevra Therapeutics reported sales of US$36.22 million, net income of US$37.89 million, and a swing to positive earnings per share, supported by a US$43.3 million gain from selling its SDX portfolio and retiring US$63.1 million of term debt. At the same time, Zevra sharpened its rare disease focus with early MyPlifer traction in Niemann-Pick disease type C, progress on celiprolol for vascular Ehlers-Danlos syndrome, and a strong cash position of US$236.8 million,...

Wondering if Shopify at around US$111.74 fairly reflects its potential, or if the stock price is getting ahead of itself. Shopify's share price has returned 18.9% over the last year, but is down 7.8% over the past week, 4.5% over the past month, and 28.9% year to date, which may have shifted how investors view its risk and opportunity. Recent coverage has focused on how Shopify fits into longer term themes in e-commerce and software, as well as how investors are reassessing growth oriented...

Wondering if Intellia Therapeutics at around US$13.71 is offering value or just volatility? This article walks through what the current price may be implying about the stock. The stock has returned 1.7% over the last 7 days, 1.2% over 30 days, 48.9% year to date and 65.6% over the past year, while longer term 3 year and 5 year returns of 69.3% and 77.5% declines show how sentiment around the stock has shifted over time. Recent headlines around Intellia Therapeutics have focused on its...

In early May 2026, AdaptHealth Corp. reported first-quarter net revenue of US$819.8 million, a wider net loss of US$16.04 million, completed a US$1.10 billion refinancing of its senior secured credit facility, and raised its 2026 net revenue guidance to US$3.45 billion–US$3.52 billion. Management highlighted that the stronger balance sheet will support disciplined tuck-in acquisitions in core Sleep and Respiratory Health, alongside a large de novo expansion and an advanced digital patient...

KeyCorp (KEY) stock is in focus after KeyBank moved to expand its Middle Market commercial banking capabilities in Southeast Michigan, targeting companies with revenues between $10 million and $1 billion across the region. See our latest analysis for KeyCorp. At a share price of US$21.69, KEY has seen a 5.19% 1 month share price return, while its 1 year total shareholder return of 45.68% and 3 year total shareholder return of about 2.8x suggest stronger momentum over longer periods despite a...

Q1 2026 results reset the earnings picture for Chime Financial (CHYM) Chime Financial (CHYM) opened 2026 with Q1 revenue of US$647.4 million and basic EPS of US$0.14, alongside net income of US$53.5 million. The trailing twelve months still show a net loss of US$956.5 million and basic EPS of US$3.03 loss. Over recent quarters, the company has seen revenue move from US$475.2 million in Q4 2024 to US$518.7 million in Q1 2025, US$528.1 million in Q2 2025, US$543.5 million in Q3 2025, US$596.4...

Waystar Holding Corp. recently reported first-quarter 2026 results, with revenue of US$313.87 million and net income of US$43.28 million, reaffirmed full-year 2026 revenue guidance of US$1.27 billion to US$1.29 billion, and in early May presented at the ECW Health Center Summit in Boston. Investor attention has also focused on Waystar’s recognition in the TIME100 Most Influential Companies list for its AltitudeAI platform, which has helped prevent a very large value of denied claims and...

StandardAero (SARO) drew investor attention after reporting first quarter 2026 results that exceeded analyst expectations on both earnings and revenue, adding fresh context to recent share price moves and valuation debates. See our latest analysis for StandardAero. The stock’s 4.71% 7 day share price return contrasts with a 14.85% decline over 90 days and a 12.18% year to date share price fall, while the 1 year total shareholder return is 6.54% lower. This suggests recent momentum is...

UDR (NYSE:UDR) has shifted to monthly dividend payments, becoming the first major apartment REIT to use this payout schedule. The company paired the change in dividend frequency with an expansion of its share repurchase program. These moves followed Q1 results that were described as better than expected. UDR focuses on owning and operating multifamily apartment communities, a segment that often attracts income focused investors looking for regular cash flow from real estate. The switch to...

In recent days, Raytheon, an RTX business, secured its largest SharpSight radar order to date with a contract from Blue Raven for 120 systems, while RTX’s board approved a quarterly dividend of US$0.73 per share, a 7.4% increase over the prior payout. These defense wins and dividend growth, alongside new long-term engine and maintenance agreements across RTX’s portfolio, underline how the company is deepening its role in critical military surveillance and commercial aviation support. We’ll...

AXT (AXTI) is back in focus after first quarter 2026 results showed sales of US$26.92 million, a sharply smaller net loss, and management guidance pointing to a possible move into profit in the next quarter. See our latest analysis for AXT. The strong first quarter update, AI data center backlog and sizeable capital raise have coincided with a sharp shift in sentiment, with AXT’s 30 day share price return of 138.5% and very large 1 year total shareholder return suggesting strong recent upside...

What Korn Ferry’s Recent Performance Data Suggests for Investors Korn Ferry (KFY) stock has moved quietly higher over the past month, with recent returns and fundamentals giving investors fresh data points on this US$3.4b organizational consulting company and its diversified revenue base. See our latest analysis for Korn Ferry. At a share price of US$67.14, Korn Ferry’s 6.05% 1 month share price return contrasts with a slightly negative 90 day move, while the 51.17% 3 year total shareholder...